(Q37271960)

19 August 2017

title

Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery (English)

1 reference

hereditary diffuse gastric cancer

19 August 2017

main subject

1 reference

2

James M Ford

1 reference

19 August 2017

3

Jeffrey A Norton

1 reference

19 August 2017

Robin M Cisco

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

113

1 reference

19 August 2017

issue

7 Suppl

1 reference

19 August 2017

page(s)

1850-1856

1 reference

Epidemiology of gastric cancer

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

21 January 2018

Familial gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

Gastric cancer: epidemiology, pathology and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

E-cadherin germline mutations in familial gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Genetic screening for hereditary diffuse gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Germline E-cadherin Gene (CDH1) Mutations Predispose to Familial Gastric Cancer and Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Germline mutations of E-cadherin gene in Korean familial gastric cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Low frequency of E-cadherin alterations in familial breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

E-cadherin as a tumor (invasion) suppressor gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

E-cadherin changes in gastric carcimona

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Germline E-cadherin mutations in familial lobular breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

A variant of early gastric carcinoma. Histologic and histochemical studies of early signet ring cell carcinomas discovered beneath preserved surface epithelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

[18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Medullary carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Evolving strategies for targeted cancer therapy--past, present, and future

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Prophylactic total gastrectomy for familial gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23650

7 January 2021

Identifiers

DOI

10.1002/CNCR.23650

1 reference

19 August 2017

1 reference